These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20190469)

  • 1. Membranous nephropathy associated with chronic hepatitis B occurring in a short period after acute hepatitis B virus infection.
    Nakahara K; Takahashi H; Okuse C; Shigefuku R; Yamada N; Murao M; Matsunaga K; Koike J; Yotsuyanagi H; Suzuki M; Kimura K; Itoh F
    Intern Med; 2010; 49(5):383-8. PubMed ID: 20190469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful Use of Entecavir in Hepatitis B-associated Membranous Nephropathy.
    Mahajan V; D'Cruz S; Nada R; Sachdev A
    J Trop Pediatr; 2018 Jun; 64(3):249-252. PubMed ID: 28977667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroconversion of hepatitis B envelope antigen by entecavir in a child with hepatitis B virus-related membranous nephropathy.
    Igarashi T; Shimizu A; Igarashi T; Hanaoka K; Yoshizaki K; Shigemori T; Shimizu S; Komeichi H; Itoh Y
    J Nippon Med Sch; 2013; 80(5):387-95. PubMed ID: 24189358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus-associated glomerulonephritis in HBsAg serological-negative patients.
    Li D; Gao G; Jiang H; Tang Z; Yu Y; Zang G
    Eur J Gastroenterol Hepatol; 2015 Jan; 27(1):65-9. PubMed ID: 25386761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defect of cell-mediated immune response against hepatitis B virus: an indication for pathogenesis of hepatitis-B-virus-associated membranous nephropathy.
    Lin CY; Lin CC; Chang GJ; King CC
    Nephron; 1997; 76(2):176-85. PubMed ID: 9200409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of occult hepatitis B virus infection related membranous nephropathy after entecavir therapy.
    Xiong QF; Zhong YD; Hu ZL; Yang YF
    Acta Clin Belg; 2015 Jun; 70(3):223-5. PubMed ID: 25510219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of hepatitis B virus-associated membranous glomerulonephritis with interferon alfa in a 7 year old boy].
    Steiss JO; Piske-Keyser K; Gröne HJ; Gortner L
    Klin Padiatr; 2000; 212(5):283-6. PubMed ID: 11048290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of polyclonal and monoclonal antibodies in determination of glomerular deposits of hepatitis B virus antigens in hepatitis B virus-associated glomerulonephritides.
    Lai KN; Lai FM; Tam JS
    Am J Clin Pathol; 1989 Aug; 92(2):159-65. PubMed ID: 2756932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membranous nephropathy related to hepatitis B virus in adults.
    Lai KN; Li PK; Lui SF; Au TC; Tam JS; Tong KL; Lai FM
    N Engl J Med; 1991 May; 324(21):1457-63. PubMed ID: 2023605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of hepatitis B virus-associated membranous nephropathy with lamivudine.
    Okuse C; Yotsuyanagi H; Yamada N; Ikeda H; Takahashi H; Suzuki M; Kondo S; Kimura K; Koike J; Itoh F
    Clin Nephrol; 2006 Jan; 65(1):53-6. PubMed ID: 16429843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HBsAg loss is not an ideal indicator for discontinuing treatment of HBeAg-negative chronic hepatitis B: a case report.
    Dong PL; Zhang X; Zhao WM; Ding HG
    J Infect Chemother; 2013 Dec; 19(6):1188-92. PubMed ID: 23783395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membranous nephropathy in 52 hepatitis B surface antigen (HBsAg) carrier children in Taiwan.
    Hsu HC; Wu CY; Lin CY; Lin GJ; Chen CH; Huang FY
    Kidney Int; 1989 Dec; 36(6):1103-7. PubMed ID: 2689751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological characteristics and prognosis of hepatitis B associated membranous nephropathy and idiopathic membranous nephropathy complicated with hepatitis B virus infection.
    Wang R; Wu Y; Zheng B; Zhang X; An D; Guo N; Wang J; Guo Y; Tang L
    Sci Rep; 2021 Sep; 11(1):18407. PubMed ID: 34526634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B 's' and 'e' antigen carriage in childhood nephrotic syndrome predicts membranous glomerulonephritis.
    Coovadia HM; Adhikari M; Moodley D
    Ann Trop Paediatr; 1993; 13(1):79-82. PubMed ID: 7681650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotype.
    Sonneveld MJ; Rijckborst V; Cakaloglu Y; Simon K; Heathcote EJ; Tabak F; Mach T; Boucher CA; Hansen BE; Zeuzem S; Janssen HL
    Antivir Ther; 2012; 17(1):9-17. PubMed ID: 22267464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of interferon-gamma inducible protein 10 kD for hepatitis B e antigen clearance and hepatitis B surface antigen decline during pegylated interferon alpha therapy in chronic hepatitis B patients.
    Wang Y; Zhao C; Zhang L; Yu W; Shen C; Wang W; Zhen Z; Zhou J
    Antiviral Res; 2014 Mar; 103():51-9. PubMed ID: 24418572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of HBsAg decline in patients with chronic hepatitis B HBeAg-negative and E genotype treated with pegylated-interferon.
    Boglione L; Cusato J; Cariti G; Di Perri G; D'Avolio A
    Antiviral Res; 2016 Dec; 136():32-36. PubMed ID: 27793564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers of hepatitis B infection in Tari District, Southern Highlands Province, Papua New Guinea.
    Sanders RC; Lewis D; Dyke T; Alpers MP
    P N G Med J; 1992 Sep; 35(3):197-201. PubMed ID: 1296422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission of hepatitis B-associated membranous glomerulonephritis in human immunodeficiency virus infection.
    Schectman JM; Kimmel PL
    Am J Kidney Dis; 1991 Jun; 17(6):716-8. PubMed ID: 2042656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration.
    Hunt CM; Beste LA; Lowy E; Suzuki A; Moylan CA; Tillmann HL; Ioannou GN; Lim JK; Kelley MJ; Provenzale D
    World J Gastroenterol; 2016 May; 22(19):4732-40. PubMed ID: 27217704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.